{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "14617519", "DateCompleted": {"Year": "2004", "Month": "03", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "09"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [{"Year": "2003", "Month": "11", "Day": "14"}], "Journal": {"ISSN": "1040-0605", "JournalIssue": {"Volume": "286", "Issue": "3", "PubDate": {"Year": "2004", "Month": "Mar"}}, "Title": "American journal of physiology. Lung cellular and molecular physiology", "ISOAbbreviation": "Am J Physiol Lung Cell Mol Physiol"}, "ArticleTitle": "Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: effect of ozone-induced SP-A oxidation.", "Pagination": {"StartPage": "L546", "EndPage": "L553", "MedlinePgn": "L546-53"}, "Abstract": {"AbstractText": ["Surfactant protein A (SP-A) plays a role in innate host defense. Human SP-A is encoded by two functional genes (SP-A1 and SP-A2), and several alleles have been characterized for each gene. We assessed the effect of in vitro expressed human SP-A genetic variants, on TNF-alpha and IL-8 production by THP-1 cells in the presence of bleomycin, either before or after ozone-induced oxidation of the variants. The oligomerization of SP-A variants was also examined. We found 1) cytokine levels induced by SP-A2 (1A, 1A(0)) were significantly higher than those by SP-A1 (6A(2), 6A(4)) in the presence of bleomycin. 2) In the presence of bleomycin, ozone-induced oxidation significantly decreased the ability of 1A and 1A/6A(4), but not of 6A(4), to stimulate TNF-alpha production. 3) The synergistic effect of bleomycin/SP-A, either before or after oxidation, can be inhibited to the level of bleomycin alone by surfactant lipids. 4) Differences in oligomerization were also observed between SP-A1 and SP-A2. The results indicate that differences among SP-A variants may partly explain the individual variability of pulmonary complications observed during bleomycin chemotherapy and/or in an environment that may promote protein oxidation."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA."}], "Identifier": [], "LastName": "Huang", "ForeName": "Weixiong", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wang", "ForeName": "Guirong", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Phelps", "ForeName": "David S", "Initials": "DS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Al-Mondhiry", "ForeName": "Hamid", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Floros", "ForeName": "Joanna", "Initials": "J"}], "GrantList": [{"GrantID": "R01 ES-09882-01", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R37 HL-34788", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Physiol Lung Cell Mol Physiol", "NlmUniqueID": "100901229", "ISSNLinking": "1040-0605"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antimetabolites, Antineoplastic"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukin-8"}, {"RegistryNumber": "0", "NameOfSubstance": "Oxidants, Photochemical"}, {"RegistryNumber": "0", "NameOfSubstance": "Pulmonary Surfactant-Associated Protein A"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "11056-06-7", "NameOfSubstance": "Bleomycin"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "Q4K217VGA9", "NameOfSubstance": "calfactant"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antimetabolites, Antineoplastic"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Bleomycin"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": [], "DescriptorName": "Electrophoresis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Insecta"}, {"QualifierName": ["genetics"], "DescriptorName": "Interleukin-8"}, {"QualifierName": [], "DescriptorName": "Mutagenesis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oxidants, Photochemical"}, {"QualifierName": [], "DescriptorName": "Oxidation-Reduction"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Pulmonary Surfactant-Associated Protein A"}, {"QualifierName": ["genetics"], "DescriptorName": "Tumor Necrosis Factor-alpha"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2003", "Month": "11", "Day": "18", "Hour": "5", "Minute": "0"}, {"Year": "2004", "Month": "3", "Day": "27", "Hour": "5", "Minute": "0"}, {"Year": "2003", "Month": "11", "Day": "18", "Hour": "5", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["14617519", "10.1152/ajplung.00267.2003", "00267.2003"]}}], "PubmedBookArticle": []}